(SeaPRwire) –   This new establishment marks the Company’s 72nd outlet in Florida and its 163rd across the nation.

STAMFORD, Conn., March 26, 2026 — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a prominent global supplier of cannabis consumer products, revealed today the inauguration of its latest dispensary in Cape Coral, situated at 345 SW 10th Pl Cape Coral, FL. With this addition, the Company’s presence in Florida expands to 72 stores, and its total store count nationwide reaches 163.

The Curaleaf Cape Coral location is ideally situated within the Shops at Del Mar shopping plaza, amidst a variety of department and apparel stores, eateries, and marketplaces. The dispensary provides Curaleaf’s premium products and brands, with expert staff on hand to assist patients throughout their purchasing journey. Among Curaleaf’s highlighted selections are the Florida-exclusive Reef flower, Select ACE vape cartridges, Anthem pre-rolls, and Select Briq vapes. This Cape Coral outlet marks the Company’s third establishment in Lee County, complementing its existing dispensaries in Fort Myers and Bonita Springs.

“Our expanding footprint in Florida, now with 72 stores across the state, underscores our dedication to the region and its medical patients,” stated Boris Jordan, Chairman and CEO of Curaleaf. “Our deep-rooted history, extensive market knowledge, and superior products enable us to strategically grow into areas requiring enhanced access to medical cannabis, all while providing an outstanding retail experience for our patients. We are eager to cater to more patients in Lee County with the launch of our Cape Coral store and anticipate revealing further store openings throughout the state in the near future.”

Curaleaf is scheduled to host a special “Meet the Manager” gathering for industry collaborators, local entrepreneurs, and community figures on Thursday, March 26, from 12:00 P.M. to 4:00 P.M., preceding the store’s official grand opening. This event will offer a chance to engage with the Curaleaf team and gain insights into the company’s dedication to patient well-being.

A two-day grand opening festivity is planned for Curaleaf Cape Coral on Friday, March 27, and Saturday, March 28, from 12:00 to 8:00 P.M. ET, encouraging patients to explore the new store, interact with the local staff, and discover Curaleaf’s premier medical cannabis selections. The celebration will include a ribbon-cutting ceremony, along with exclusive promotions and prizes, such as a Puffco 3DXL, a behind-the-scenes cultivation tour providing an intimate view of Curaleaf’s growing process from seed to harvest, and a $250 store credit. The store’s operating hours are 9:00 A.M. to 8:30 P.M. ET, Monday through Saturday, and 10:00 A.M. to 7 P.M. ET on Sundays.

To learn more about Curaleaf’s dispensaries in Florida, its product range, and patient support resources, kindly visit https://curaleaf.com/dispensary/florida.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf”) stands as a premier global supplier of cannabis consumer products, dedicated to improving lives by nurturing, distributing, and honoring the plant’s potential. As a rapidly expanding cannabis enterprise recognized for its excellence, proficiency, and dependability, the Company and its various brands—including Curaleaf, Select, Grassroots, Find, and Anthem—deliver unparalleled service, product variety, and availability across both medical and adult-use sectors. Curaleaf International benefits from a robust involvement at every stage of the supply chain. Its distinctive distribution network spanning Europe, Canada, and Australasia integrates groundbreaking scientific research with advanced cultivation, extraction, and manufacturing techniques. Curaleaf is publicly traded on the Toronto Stock Exchange under the ticker CURA and on the OTCQX market as CURLF. For further details, please visit https://ir.curaleaf.com.

Forward Looking Statements
This media announcement includes forward-looking statements and forward-looking data as defined by relevant securities legislation. These declarations pertain to prospective occurrences or future performance. Any statement not presenting historical fact could be considered a forward-looking statement or piece of information. Typically, forward-looking statements and information can be recognized by terms such as “plans,” “expects,” or “proposed,” “is expected,” “intends,” “anticipates,” or “believes,” or variations of these terms and expressions, or by phrases indicating that certain actions, events, or outcomes may, could, would, or might transpire or be realized. Specifically, and without restriction, this news release features forward-looking statements and information regarding the launch of a dispensary in Cape Coral, Florida. Such forward-looking statements and information are a reflection of management’s current perspectives and are founded on assumptions made by, and data presently accessible to, the company concerning the subject matter detailed in this new release. Forward-looking statements carry inherent risks and uncertainties, which are grounded in current expectations as of this release’s date and are subject to identified and unidentified risks and uncertainties that could lead actual outcomes to diverge significantly from those stated or suggested by such declarations. Further details concerning these assumptions and uncertainties can be found under “Risk Factors and Uncertainties” in the Company’s most recent annual information form, submitted on February 26, 2026, accessible via the Company’s SEDAR profile at http://www.sedar.com, and in other submissions the Company has made or may make to pertinent securities authorities hereafter. The forward-looking statements presented herein are valid only as of the date of this press release, and we disclaim any responsibility to update or amend any forward-looking statements, whether due to new information, future events, or otherwise, unless legally mandated. We advise investors against placing undue reliance on the forward-looking statements within this press release. The Toronto Stock Exchange has neither reviewed, endorsed, nor rejected the content of this news release.

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com

SOURCE Curaleaf Holdings, Inc.